Why We Should Improve Current Practice of Diagnosing and Treating Pulmonary Large Cell Neuroendocrine Carcinomas in Patients With Advanced Disease

European Respiratory Journal - United Kingdom
doi 10.1183/13993003.01658-2017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Transfusion in Trauma: Why and How Should We Change Our Current Practice?

Current Opinion in Anaesthesiology
AnesthesiologyPain Medicine
2009English

Chemotherapy for Pulmonary Large Cell Neuroendocrine Carcinomas: Does the Regimen Matter?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

A Single-Institution Analysis of the Surgical Management of Pulmonary Large Cell Neuroendocrine Carcinomas

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2016English

Pulmonary Large Cell Neuroendocrine Carcinoma

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2006English

Topotecan Monotherapy in Heavily Pretreated Patients With Progressive Advanced Stage Neuroendocrine Carcinomas

Journal of Cancer
Oncology
2014English

Pulmonary Neuroendocrine Carcinomas: Progress and Pitfalls

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Combined Treatment of Patients With Pancreatic Neuroendocrine Carcinomas

Annals of HPB Surgery
HepatologySurgeryGastroenterology
2018English

Hepatocellular Carcinoma and Sorafenib: How Can We Improve on the Current Standard of Care in Advanced Disease?

Advanced Research in Gastroenterology & Hepatology
2017English

Should We Exclude Elderly Patients With Chronic Obstructive Pulmonary Disease From a Long-Time Ambulatory Pulmonary Rehabilitation Programme?

Journal of Rehabilitation Medicine
MedicinePhysical TherapySports TherapyRehabilitationSports Science
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy